Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature

Glioblastoma is a devastating disease, for which biomarkers allowing a prediction of prognosis are urgently needed. microRNAs have been described as potentially valuable biomarkers in cancer. Here, we studied a panel of microRNAs in extracellular vesicles (EVs) from the serum of glioblastoma patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzaridis, Theophilos, Reiners, Katrin S, Weller, Johannes, Bachurski, Daniel, Schäfer, Niklas, Schaub, Christina, Hallek, Michael, Scheffler, Björn, Glas, Martin, Herrlinger, Ulrich, Wild, Stefan, Coch, Christoph, Hartmann, Gunther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583802/
https://www.ncbi.nlm.nih.gov/pubmed/33003586
http://dx.doi.org/10.3390/ijms21197211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583802/
https://www.ncbi.nlm.nih.gov/pubmed/33003586
http://dx.doi.org/10.3390/ijms21197211

Ejemplares similares